Health Care: Drugs

Pharmacyclics Inc (PCYC: NASDAQ)

$123.52 n/a | n/a%
09/19/14 - 03:59 PM ET
Ratio Comparisons
Company Industry S&P 500
Valuation Ratios
P/E Ratio (TTM) 110.40 n.a. 28.89
P/E High - Last 5 Yrs n.a. n.a. 42.89
P/E Low - Last 5 Yrs n.a. n.a. 9.55
Beta 0.75 0.46 1.07
Price to Sales (TTM) 21.37 10.63 2.87
Price to Book (MRQ) 14.25 8.18 6.16
Price to Tangible Book (MRQ) 14.45 34.88 2.58
Price to Cash Flow (TTM) 102.00 76.50 17.38
Price to Free Cash Flow (TTM) 76.90 -56.40 21.85
Dividends
Dividend Yield (%) 0.00 0.40 1.86
Dividend Yield - 5 Yr Avg (%) n.a. 0.20 2.44
Dividend 5 Yr Growth Rate (%) n.a. 31.86 13.00
Payout Ratio (TTM) 0.00 n.a. 42.75
Sales (MRQ) vs Qtr 1 Yr Ago (%) 106.70 41.90 10.18
Sales (TTM) vs TTM 1 Yr Ago (%) 61.90 16.10 5.66
Growth Rates (%)
Sales - 5 Yr Growth Rate (%) n.a. 6.16 6.93
EPS (MRQ) vs Qtr 1 Yr Ago (%) -100.00 64.70 42.73
EPS (TTM) vs TTM 1 Yr Ago (%) -100.00 64.70 42.73
EPS - 5 Yr Growth Rate (%) n.a. n.a. 10.39
Capital Spending - 5 Yr Growth Rate (%) n.a. 23.13 10.25
Financial Strength
Quick Ratio (MRQ) 5.60 2.60 1.25
Current Ratio (MRQ) 6.00 3.10 1.90
LT Debt to Equity (MRQ) 0.00 0.59 1.65
Total Debt to Equity (MRQ) 0.00 0.68 1.79
Interest Coverage (TTM) n.a. 5.60 59.76
Profitability Ratios (%)
Gross Margin (TTM) 79.10 87.70 47.29
Gross Margin - 5 Yr Avg 99.80 85.90 46.62
EBITD Margin (TTM) 28.30 22.90 25.36
EBITD - 5 Yr Avg 1.39 0.00 0.00
Pre-Tax Margin (TTM) 27.60 13.00 15.88
Pre-Tax Margin - 5 Yr Avg 34.00 14.20 13.93
Management Effectiveness (%)
Net Profit Margin (TTM) 20.20 7.61 9.26
Net Profit Margin - 5 Yr Avg 28.10 9.70 10.62
Return on Assets (TTM) 10.60 2.40 6.98
Return on Assets - 5 Yr Avg 9.50 3.90 6.48
Return on Investment (TTM) 13.50 3.20 12.62
Return on Investment - 5 Yr Avg 12.30 5.20 11.11
Efficiency
Revenue/Employee (TTM) 898,835.00 798,948.00 947,898.00
Net Income/Employee (TTM) 181,380.00 53,376.00 112,572.80
Receivable Turnover (TTM) 10.00 5.90 21.78
Inventory Turnover (TTM) 4.70 1.10 13.44
Asset Turnover (TTM) 0.60 0.40 0.81

Portfolios with PCYC

Latest PCYC Headlines from TheStreet

More Financial News for PCYC

Press Releases for PCYC

See All Press Releases

Partner Headlines for PCYC

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter